Healthcare - Medical - Devices - NASDAQ - US
$ 0.0662
-10.5 %
$ 1.78 M
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-8.31 M
OPERATING CASH FLOW
-704 K
INVESTING CASH FLOW
1.11 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Bluejay Diagnostics, Inc.
| Net Income | -9.95 M |
| Depreciation & Amortization | 781 K |
| Capital Expenditures | -704 K |
| Stock-Based Compensation | 189 K |
| Change in Working Capital | 667 K |
| Others | 906 K |
| Free Cash Flow | -9.02 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (10.0) | (9.3) | (3.5) | (1.2) | (0.8) |
| Depreciation & Amortization | 0.8 | 0.3 | 0.1 | 0.2 | 0.1 |
| Deferred Income Tax | 0 | 0 | 0.2 | 42.4 K | 9.84 K |
| Stock Based Compensation | 0.2 | 0.4 | 68.5 K | 7.37 K | 14.8 K |
| Other Operating Activities | 3.09 K | 0.2 | 0.2 | (0.2) | (0.8) |
| Change in Working Capital | 0.7 | 0.6 | (1.5) | 0.6 | (0.2) |
| Cash From Operations | (8.3) | (7.7) | (4.4) | (0.5) | (1.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.7) | (1.2) | 23.9 K | 0 | 6.02 K |
| Other Items | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.7) | (1.2) | 23.9 K | 0 | 6.02 K |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 4.81 K | 801 | 4.2 | 0.3 | (0.3) |
| Dividends Paid | 0 | 0 | 17.7 K | 0 | 0 |
| Other Financing Activities | 1.0 | 8.88 K | (0.5) | 1.1 | 1.8 |
| Cash From Financing Activities | 1.1 | 8.08 K | 22.5 | 1.3 | 1.5 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (7.9) | (8.9) | 18.1 | 0.8 | (0.2) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (9.0) | (8.9) | (4.4) | (0.5) | (1.7) |